Andrew S. Janoff
80Patents
34h-index
68Co-inventors
91Inventor score
Filing activity: Mar 24, 1983 → Jul 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4522803A | Stable plurilamellar vesicles, their preparation and use | Emerging Cross-Sectional Technologies | 276 | Expired |
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US5169637A | Stable plurilamellar vesicles | Emerging Cross-Sectional Technologies | 146 | Expired |
| US4721612A | Steroidal liposomes | Emerging Cross-Sectional Technologies | 136 | Expired |
| US4975282A | Multilamellar liposomes having improved trapping efficiencies | Human Necessities | 126 | Expired |
| US5154930A | Pharmacological agent-lipid solution preparation | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5030453A | Stable plurilamellar vesicles | Human Necessities | 102 | Expired |
| US6090406A | Potentiation of immune responses with liposomal adjuvants | Emerging Cross-Sectional Technologies | 100 | Expired |
| US5059591A | Drug preparations of reduced toxicity | Human Necessities | 100 | Expired |
| US5409704A | Liposomes comprising aminoglycoside phosphates and methods of production and use | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6339069B1 | Peptide-lipid conjugates, liposomes and lipsomal drug delivery | Human Necessities | 67 | Expired |
| US6406713B1 | Methods of preparing low-toxicity drug-lipid complexes | Emerging Cross-Sectional Technologies | 64 | Expired |
| US4897384A | Drug preparations of reduced toxicity | Human Necessities | 61 | Expired |
| US6086851A | Pharmaceutical compositions containing interdigitation-fusion liposomes and gels | Emerging Cross-Sectional Technologies | 60 | Expired |
| US5922350A | Methods of dehydrating, storing and rehydrating liposomes | Human Necessities | 59 | Expired |
| US5616334A | Low toxicity drug-lipid systems | Emerging Cross-Sectional Technologies | 58 | Expired |
| US6087325A | Peptide-lipid conjugates | Human Necessities | 57 | Expired |
| US5041278A | Alpha tocopherol-based vesicles | Emerging Cross-Sectional Technologies | 56 | Expired |
| US5415867A | High ratio active agent: lipid complex | Emerging Cross-Sectional Technologies | 55 | Expired |
| US4891208A | Steroidal liposomes | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5820848A | Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent | Emerging Cross-Sectional Technologies | 51 | Expired |
| US5916588A | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use | Human Necessities | 50 | Expired |
| US7842676B2 | Fixed ratio drug combination treatments for solid tumors | Human Necessities | 47 | Active |
| US5578320A | Method of dehydrating liposomes using protective sugars | Human Necessities | 46 | Expired |
| US6120797A | N-acyl phosphatidylethanolamine-mediated liposomal drug delivery | Emerging Cross-Sectional Technologies | 46 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.